How orforglipron, semaglutide, and tirzepatide are reshaping primary-care prescribing — read in plain English by a working physician.
52 stories · Updated Jul 6, 2026
Reading Time: 8 minutesA Medicare patient sits in your clinic and asks about Wegovy or Foundayo. The conversation usually pivots on a single question. Can you offer a realistic path to coverage? For a long...
Reading Time: 9 minutesAmazon's appointment of Roy Schoenberg signals an aggressive expansion into asynchronous weight management. Primary care practices must adapt to retain complex metabolic patients.
Reading Time: 10 minutesAuthor: Dr. Ahmed Zayed, MD Reviewed: [pending physician sign-off] Word count: ~2450 Track: ZayedMD canonical Status: Draft 1, Gemini-drafted with PubMed evidence (daily pipeline 2026-05-30) News anchor: https://www.statnews.com/2026/05/29/glp-1-microdose-popular-but-unsupported-by-evidence/ Focus keyphrase: GLP-1 microdosing...
Reading Time: 10 minutesAuthor: Dr. Ahmed Zayed, MD Reviewed: [pending physician sign-off] Word count: ~2450 Track: ZayedMD canonical Status: Draft 1, Gemini-drafted with PubMed evidence (daily pipeline 2026-05-30) News anchor: https://www.statnews.com/2026/05/29/glp-1-microdose-popular-but-unsupported-by-evidence/ Focus keyphrase: GLP-1 microdosing...